Sign in
8-K

Current Report

Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-239246

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d111034d8k.htm…